Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (121-130 of 320) with videos related to

Pageof 32
Sort By:
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2026
Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort StudyAlexandra Lukey, Helena Abreu do Valle, A Fuchsia Howard, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Gynecologic Oncology|October 29, 2017
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent mannerYuyin Yi, Shu-Huei Tsai, Jung-Chien Cheng, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
The American Journal of Surgical Pathology|May 28, 2010
Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian studyMartin Köbel, Steve E Kalloger, Patricia M Baker, et al.
BMC Medicine|November 17, 2007
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaLeah M Prentice, Christian Klausen, Steve Kalloger, et al.
Human Reproduction (Oxford, England)|December 19, 2024
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal studyDwayne R Tucker, Anna F Lee, Natasha L Orr, et al.
Plos One|December 4, 2009
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumorsKasmintan A Schrader, Bella Gorbatcheva, Janine Senz, et al.
Pageof 32

Showing results (121-130 of 320) with videos related to

Sort By:
Pageof 32
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2026
Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort StudyAlexandra Lukey, Helena Abreu do Valle, A Fuchsia Howard, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Gynecologic Oncology|October 29, 2017
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent mannerYuyin Yi, Shu-Huei Tsai, Jung-Chien Cheng, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
The American Journal of Surgical Pathology|May 28, 2010
Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian studyMartin Köbel, Steve E Kalloger, Patricia M Baker, et al.
BMC Medicine|November 17, 2007
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaLeah M Prentice, Christian Klausen, Steve Kalloger, et al.
Human Reproduction (Oxford, England)|December 19, 2024
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal studyDwayne R Tucker, Anna F Lee, Natasha L Orr, et al.
Plos One|December 4, 2009
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumorsKasmintan A Schrader, Bella Gorbatcheva, Janine Senz, et al.
Pageof 32